Expression of Vascular Endothelial Growth Factor correlates with the advance of clinical osteosarcoma

1 Osteosarcoma of the mobile spine Annals of Oncology, April 25, 2013

2 Survival of pediatric patients after relapsed osteosarcoma: The St. Jude Childrens Research Hospital experience Cancer, May 2, 2013

3 Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma European Journal of Cancer, May 10, 2013

4 A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma Tumor Biology, April 17, 2013    Review Article

5 A Disintegrin And Metalloproteinase 12 produced by tumour cells accelerates osteosarcoma tumour progression and associated osteolysis European Journal of Cancer, April 26, 2013

6 Alpha-CaMKII Plays a Critical Role in Determining the Aggressive Behavior of Human Osteosarcoma Molecular Cancer Research, April 17, 2013

7 The Correlation Between Dose of Folinic Acid and Neurotoxicity in Children and Adolescents Treated for Osteosarcoma With High-dose Methotrexate (HDMTX): A Neuropsychological and Psychosocial Study Journal of Pediatric Hematology/Oncology, May 3, 2013

8 Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis Journal of Clinical Oncology, May 17, 2013    Review Article

9 Minnelide reduces tumor burden in preclinical models of osteosarcoma Cancer Letters, April 30, 2013

10 Antibody-dependent cell lysis by NK cells is preserved after sarcoma-induced inhibition of NK cell cytotoxicity Cancer Immunology, Immunotherapy, April 29, 2013